HOME >> BIOLOGY >> NEWS
Einstein researchers find 'key' to unlocking world's deadliest malaria parasite

Researchers at the Albert Einstein College of Medicine of Yeshiva University have leveraged the results of their research into tuberculosis to craft a tool for unlocking the secrets of another of the world's leading infectious killers--malaria.

These findings, published in the August issue of Nature Methods, "should substantially speed up research efforts to bring malaria under control," says Dr. David Fidock, senior author of the paper and an associate professor of microbiology & immunology at Einstein.

Malaria is caused by a single-celled parasite, Plasmodium, which is transmitted through the bite of the Anopheles mosquito. The disease kills an estimated 1.2 million people every year.

The Einstein scientists focused on the most deadly Plasmodium strain--P. falciparum--which is proving increasingly resistant to treatment. Their research has led to the first efficient technique for inserting any gene of interest into the P. falciparum genome to gain biological information that could lead to more effective treatments.

"This opens up a whole new window into the genetic manipulation of this lethal parasite," says Dr. William Jacobs, who is a Howard Hughes investigator and professor of molecular genetics and microbiology & immunology at Einstein and a major author of the Nature Methods paper. "Malaria researchers finally have an efficient way to shuffle genes into P. falciparum, which should lead to valuable information about the parasite's virulence, how it's transmitted from mosquito to humans and how it develops resistance to antimalarial drugs."

The research effort was conducted primarily by Louis Nkrumah, an MD/PhD student at Einstein. Central to this effort was a bacterial phage (virus) that Dr. Jacobs isolated from soil in his backyard in the Bronx and dubbed the "Bronx Bomber." It infects Mycobacterium smegmatis, a bacterial species closely related to Mycobacterium tuberculosis, which causes tuberculosis. Dr
'"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
25-Jul-2006


Page: 1 2

Related biology news :

1. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
2. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
3. Einstein researchers discover radiation-eating fungi
4. Einsteins Dr. Vern Schramm elected to the National Academy of Sciences
5. Einstein researchers discover how a key dietary vitamin is absorbed
6. NCI funds Einstein and U. Albany NanoCollege to make worlds smallest cancer detection device
7. Team at CNSE and Einstein receive grant to develop worlds smallest cancer detection device
8. Einstein researchers demonstrate a novel approach to treating AIDS
9. Einsteins Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize
10. Findings by Einstein scientists reveal possible strategy against obesity, diabetes and infertility
11. Einstein researchers take the pulse of a gene in living cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... ... August 16, 2018 , ... With increasing safety requirements, and ... research projects, are presenting multiple challenges. To be successful in such a competitive environment, ... different aspects of the multiple tasks needed to develop a new drug or to ...
(Date:8/14/2018)... ... 2018 , ... Career fairs provide an ideal setting for ... at once. However, healthcare professionals often have hectic schedules with little spare time ... providers who wish to explore opportunities and learn about multiple employers from the ...
(Date:8/14/2018)... ... August 14, 2018 , ... ... and commercialization, is announcing the keynote for their NAVIGATE2018 conference. , ... as keynote speaker for NAVIGATE2018 , Cognition’s annual user conference. An experienced ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... ... July 25, 2018 , ... ... its state-of-the-art Digital Vivarium™ and Vium Cloud approach to accelerate preclinical drug discovery ... Officer. Additionally, the company announced the appointment of Jeff Caron to the newly ...
(Date:7/25/2018)... ... 2018 , ... John McDonald, CEO of ClearObject , ... India Business Council (IIBC), an advocacy group to strengthen economic ties between Indiana ... McDonald joins an impressive roster of local and national business leaders from organizations ...
(Date:7/24/2018)... Texas (PRWEB) , ... July 24, 2018 , ... Boval ... to support blood bank reagent suppliers. In Boval’s early days most of the ... were added to produce BSA for diagnostic purposes after gel cards changed that market ...
(Date:7/22/2018)... ... 19, 2018 , ... Mitotech S.A, a Luxembourg based clinical ... 3 clinical program in Dry Eye Disease. Under the agreement Essex Bio-Investment will ... towards the first Phase 3 study starting as early as Fall 2018. ...
Breaking Biology Technology:
Cached News: